FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Saved in:
| Title: | FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders. |
|---|---|
| Authors: | Lui, Austin1 (AUTHOR), Vanleuven, Jordan1 (AUTHOR), Perekopskiy, David1 (AUTHOR), Liu, Dewey1 (AUTHOR), Xu, Desiree1 (AUTHOR), Alzayat, Omar1 (AUTHOR), Elgokhy, Taiseer1 (AUTHOR), Do, Timothy1 (AUTHOR), Gann, Meghan1 (AUTHOR), Martin, Ryan2 (AUTHOR), Liu, Da-Zhi1,3 (AUTHOR) dzliu@ucdavis.edu |
| Source: | Pharmaceuticals (14248247). Dec2022, Vol. 15 Issue 12, p1546. 30p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph15121546 |